entertainment -WSS

entertainment

author：entertainment 2025-09-28 18:59:17 - browse：13129

Who polices algorithms? How would you name the first approved CRISPR medicine? And what pairs well with a biotech downturn?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability. Then, biotech veteran Michael Gilman calls in to offer a behind-the-scenes peek at what it’s like to be a startup CEO in this economic downturn — and which cocktail recipes help make it bearable. We also discuss a pioneering approval for a genome-editing medicine.

For more on what we cover, here’s the UnitedHealth story; here’s more on the CRISPR approval; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Wegovy improves function in certain heart failure patients

knowledge

entertainment

WSS

PBMs are inflating the cost of generic drugs. They must be reined in

Why depression after traumatic brain injury is distinct

Study: Spinal cord stimulation helps patients with paralysis walk again

Readout Newsletter: Bristol, Sangamo, Gilead, and more

How to save health care price transparency rules

Ebola: Gilead Sciences antiviral shows promise as new treatment

explore

entertainment

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Amid AI frenzy, a top HHS official's quest to create safeguards

Tori Bowie and the unacceptable rates of Black maternal death

How to save health care price transparency rules

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA advisers back CAR

Affirmative action in medical school literally saved lives

First U.S. drug developed to treat liver disease MASH is approved

Trump demands the U.S. pay no more for drugs than other countries … again

How the first Native Hawaiian psychiatrist helped diversify medicine

hotspot

Pushing for an NIH office for post

Roche's accidental data boosts hopes for anti

HHS secretary Becerra pressed on Change HealthCare cyberattack

Hospital at home shows how to bring innovation to health care

California store owner shot dead in dispute over displaying Pride flag: Police

First U.S. drug developed to treat liver disease MASH is approved

knowledge

entertainment

knowledge

focus